Diabetes Care:糖尿病患者非创伤性下肢截肢发病率减少

2012-10-09 Diabetes Care Diabetes Care

  苏格兰的一项队列研究表明,在2004年和2008年间,苏格兰糖尿病患者的非创伤性下肢截肢(LEA)发病率显著减少,其中,大的LEA的发病率减少更为显著。研究在2012年9月25日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究旨在调查苏格兰地区糖尿病患者非创伤性下肢截肢(LEA)的发病率。研究利用了国家的发病率记录和糖尿病数据库,评估了2004年至2008年

  苏格兰的一项队列研究表明,在2004年和2008年间,苏格兰糖尿病患者的非创伤性下肢截肢(LEA)发病率显著减少,其中,大的LEA的发病率减少更为显著。研究在2012年9月25日在线发表于《糖尿病护理》(Diabetes Care)杂志。

  该研究旨在调查苏格兰地区糖尿病患者非创伤性下肢截肢(LEA)的发病率。研究利用了国家的发病率记录和糖尿病数据库,评估了2004年至2008年在苏格兰接受大的和小的非创伤性LEA的糖尿病患者数量。

  结果表明,在2004-2008期间纳入的1382例进行非创伤性LEA的糖尿病患者中,57.1%(n=1359)接受了大的LEA。在五年随访期间内,糖尿病患者任何LEA的发生率为29.8%:其中,2004年为2.13 例/1000例,2008年为3.04 例/1000例(P<0.001)。大的LEA率下降了40.7%,从2004年的1.87 例/1000例降至1.11例/1000例(P<0.001)。

  链接:

Kennon B, Leese GP, Cochrane L, Colhoun H, Wild S, Stang D, Sattar N, Pearson D, Lindsay RS, Morris AD, Livingstone S, Young M, McKnight J, Cunningham S.Reduced Incidence of Lower-Extremity Amputations in People with Diabetes in Scotland:A nationwide study.Diabetes Care. 2012 Sep 25

  



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1823162, encodeId=54a9182316213, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Apr 29 21:51:00 CST 2013, time=2013-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636581, encodeId=2d8e163658146, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 25 19:51:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025409, encodeId=9c702025409d0, content=<a href='/topic/show?id=66f93204223' target=_blank style='color:#2F92EE;'>#创伤性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32042, encryptionId=66f93204223, topicName=创伤性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Sun Feb 17 01:51:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759205, encodeId=63771e59205aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Aug 11 06:51:00 CST 2013, time=2013-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901014, encodeId=066d1901014e5, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jul 04 12:51:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335035, encodeId=297a1335035e5, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388148, encodeId=545f13881489b, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473670, encodeId=6ea214e3670b4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1823162, encodeId=54a9182316213, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Apr 29 21:51:00 CST 2013, time=2013-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636581, encodeId=2d8e163658146, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 25 19:51:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025409, encodeId=9c702025409d0, content=<a href='/topic/show?id=66f93204223' target=_blank style='color:#2F92EE;'>#创伤性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32042, encryptionId=66f93204223, topicName=创伤性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Sun Feb 17 01:51:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759205, encodeId=63771e59205aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Aug 11 06:51:00 CST 2013, time=2013-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901014, encodeId=066d1901014e5, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jul 04 12:51:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335035, encodeId=297a1335035e5, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388148, encodeId=545f13881489b, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473670, encodeId=6ea214e3670b4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1823162, encodeId=54a9182316213, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Apr 29 21:51:00 CST 2013, time=2013-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636581, encodeId=2d8e163658146, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 25 19:51:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025409, encodeId=9c702025409d0, content=<a href='/topic/show?id=66f93204223' target=_blank style='color:#2F92EE;'>#创伤性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32042, encryptionId=66f93204223, topicName=创伤性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Sun Feb 17 01:51:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759205, encodeId=63771e59205aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Aug 11 06:51:00 CST 2013, time=2013-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901014, encodeId=066d1901014e5, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jul 04 12:51:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335035, encodeId=297a1335035e5, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388148, encodeId=545f13881489b, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473670, encodeId=6ea214e3670b4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=)]
    2013-02-17 amyloid
  4. [GetPortalCommentsPageByObjectIdResponse(id=1823162, encodeId=54a9182316213, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Apr 29 21:51:00 CST 2013, time=2013-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636581, encodeId=2d8e163658146, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 25 19:51:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025409, encodeId=9c702025409d0, content=<a href='/topic/show?id=66f93204223' target=_blank style='color:#2F92EE;'>#创伤性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32042, encryptionId=66f93204223, topicName=创伤性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Sun Feb 17 01:51:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759205, encodeId=63771e59205aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Aug 11 06:51:00 CST 2013, time=2013-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901014, encodeId=066d1901014e5, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jul 04 12:51:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335035, encodeId=297a1335035e5, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388148, encodeId=545f13881489b, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473670, encodeId=6ea214e3670b4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1823162, encodeId=54a9182316213, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Apr 29 21:51:00 CST 2013, time=2013-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636581, encodeId=2d8e163658146, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 25 19:51:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025409, encodeId=9c702025409d0, content=<a href='/topic/show?id=66f93204223' target=_blank style='color:#2F92EE;'>#创伤性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32042, encryptionId=66f93204223, topicName=创伤性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Sun Feb 17 01:51:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759205, encodeId=63771e59205aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Aug 11 06:51:00 CST 2013, time=2013-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901014, encodeId=066d1901014e5, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jul 04 12:51:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335035, encodeId=297a1335035e5, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388148, encodeId=545f13881489b, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473670, encodeId=6ea214e3670b4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1823162, encodeId=54a9182316213, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Apr 29 21:51:00 CST 2013, time=2013-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636581, encodeId=2d8e163658146, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 25 19:51:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025409, encodeId=9c702025409d0, content=<a href='/topic/show?id=66f93204223' target=_blank style='color:#2F92EE;'>#创伤性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32042, encryptionId=66f93204223, topicName=创伤性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Sun Feb 17 01:51:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759205, encodeId=63771e59205aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Aug 11 06:51:00 CST 2013, time=2013-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901014, encodeId=066d1901014e5, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jul 04 12:51:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335035, encodeId=297a1335035e5, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388148, encodeId=545f13881489b, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473670, encodeId=6ea214e3670b4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1823162, encodeId=54a9182316213, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Apr 29 21:51:00 CST 2013, time=2013-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636581, encodeId=2d8e163658146, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 25 19:51:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025409, encodeId=9c702025409d0, content=<a href='/topic/show?id=66f93204223' target=_blank style='color:#2F92EE;'>#创伤性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32042, encryptionId=66f93204223, topicName=创伤性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Sun Feb 17 01:51:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759205, encodeId=63771e59205aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Aug 11 06:51:00 CST 2013, time=2013-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901014, encodeId=066d1901014e5, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jul 04 12:51:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335035, encodeId=297a1335035e5, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388148, encodeId=545f13881489b, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473670, encodeId=6ea214e3670b4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1823162, encodeId=54a9182316213, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Apr 29 21:51:00 CST 2013, time=2013-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636581, encodeId=2d8e163658146, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 25 19:51:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025409, encodeId=9c702025409d0, content=<a href='/topic/show?id=66f93204223' target=_blank style='color:#2F92EE;'>#创伤性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32042, encryptionId=66f93204223, topicName=创伤性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Sun Feb 17 01:51:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759205, encodeId=63771e59205aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Aug 11 06:51:00 CST 2013, time=2013-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901014, encodeId=066d1901014e5, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jul 04 12:51:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335035, encodeId=297a1335035e5, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388148, encodeId=545f13881489b, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473670, encodeId=6ea214e3670b4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Oct 11 01:51:00 CST 2012, time=2012-10-11, status=1, ipAttribution=)]

相关资讯

Circulation:即刻血运重建有益高危糖尿病心脏病患者(BARI 2D研究)

  美国学者在大型BARI 2D试验中表明,在伴有广泛冠脉病变或左室功能受损的糖尿病患者中,即刻冠脉搭桥术(CABG)策略可显著降低死亡/心梗/卒中发生率。论文于2012年9月24日在线发表于《循环》(Circulation)杂志。   BARI 2D试验给予2型糖尿病患者即可冠脉血运重建(REV)联合强化内科治疗(MED)或单纯MED。此项研究依据患者随机化时评估指标制定血管造影风险

Diabetes Care:甘精胰岛素不增加肿瘤风险(法国研究)

  一项基于法国国家管理数据库的队列研究表明,在新开始基础胰岛素治疗的较大患者队列中,与使用其他基础胰岛素的患者相比,接受甘精胰岛素治疗的患者未发现恶性肿瘤风险增加。然而,由于随访时间不超过4年,进一步更长期的研究尤为必要。研究在2012年9月10日在线发表于《糖尿病护理》(Diabetes Care)杂志。  该研究旨在探讨与其他基础胰岛素相比,甘精胰岛素的使用与2型糖尿病患者的总体和

CCQO:极端气温升高心血管死亡风险

  澳大利亚学者的一项研究表明,热浪和寒潮期间的极端气温可升高心血管疾病早亡风险。论文在线发表于《循环:心血管质量与结果》(Circ Cardiovasc Qual Outcomes)杂志。   暴露于极端气温可诱发血压、血液粘稠度、胆固醇和心率变化。随着肥胖和糖尿病等相关疾病发病率升高,易受极端气温影响的人群亦不断增多,并且可升高未来疾病负担。此项研究采集了澳大利

NEJM评论:II型糖尿病的预防障碍在哪里

 美国糖尿病预防项目(Diabetes Prevention Program,DPP) 临床试验及其10年转归研究(DPPOS)均得到美国国立卫生研究院(NIH)资助,研究结果显示,某些特定的干预措施可以预防或显著地阻止2型糖尿病的发生,安全性和效价比均很可观。然而,糖尿病预防措施并没有在美国得到推广,人力和财力成本惊人并呈不断增长的态势。因此有必要明确是什么原因阻止了DPP糖尿病预防干

联合国再开NCD高级别会议

  2012年9月19日,联合国再次举行了非传染性疾病(NCD)高级别会议。出席会议的包括美国癌症协会(ACS)主席约翰·塞弗林,美国糖尿病协会(ADA)主席拉里·豪斯纳和美国心脏协会主席(AHA)南希·布朗。会议有助于提升非传染性疾病的重要性,并将慢性非传染性疾病(包括恶性肿瘤、糖尿病、心血管疾病,慢性呼吸系统疾病)提上全球健康议程。会议达成联合国一致通过的“关于预防和控制非传染性疾病问题高级别

Journal of Diabetes(《糖尿病期刊》)被SCIE收录

2012年Journal of Diabetes《糖尿病期刊》被汤森路透的SCIE(Science Citation Index Expanded)收录,首个影响因子将于2013年6月公布。这是继2010年6月被MEDLINE收录以来,本刊所取得的又一个里程碑式的进步。 Journal of Diabetes由上海交通大学瑞金医院与国际著名期刊出版集团Wiley-Blackwell于2009年联